Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

John S. Montalbano

Director at AbCellera Biologics Inc. (ABCL)

Purchase track record

Strong record. Based on 2 purchases with a full 90 days of price history.

99
Avg. 90-day return+78.8%
vs. S&P 500+75.7%
Beat the market50%
Paper profit on buys+$619K
Total bought / sold$384K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 18SEC ABCLAbCellera Biologics Inc. Buy 10,000251,000 held (+4%) $11.03 $110K +13.7%
May 18SEC ABCLAbCellera Biologics Inc. Buy 20,000241,000 held (+9%) $4.77 $95K +163.0%
Nov 26SEC ABCLAbCellera Biologics Inc. Buy 50,000221,000 held (+29%) $3.57 $178K +251.4%
  • Buy

    Director John S. Montalbano bought $178K of ABCL at $3.57 — first open-market purchase in our records; raises the stake by 29%.